‘Reactivation of immune checkpoints by an epitope-specific vaccine reinstates tolerogenic pathways and induces clinical amelioration in patients with rheumatoid arthritis.’

Poster presentation on the 16th of June at 10:30 (SAT0232) by the Albani lab.

View the abstract
Website EULAR 2018, in Amsterdam